The biochemical defect in Farber's disease.

[1]  H. Moser,et al.  Diagnosis of lipogranulomatosis (Farber disease) by use of cultured fibroblasts. , 1976, The Journal of pediatrics.

[2]  H. Moser,et al.  Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase. , 1975, Biochimica et biophysica acta.

[3]  H. Moser,et al.  Above-normal urinary excretion of urinary ceramides in Farber's disease, and characterization of their components by high-performance liquid chromatography. , 1975, Clinical chemistry.

[4]  H. Hers,et al.  Lysosomes and storage diseases , 1973 .

[5]  P. Dustin,et al.  LA MALADIE DE FARBER. ETUDE ANATOMO CLINIQUE ET ULTRASTRUCTURALE , 1973 .

[6]  H. Moser,et al.  Ceramidase Deficiency in Farber's Disease (Lipogranulomatosis) , 1972, Science.

[7]  R. Zetterström,et al.  Ceramides in a patient with lipogranulomatosis (Farber's disease) with chronic course. , 1971, Scandinavian journal of clinical and laboratory investigation.

[8]  J. Clausen,et al.  CHEMICAL STUDIES OF FARBER'S DISEASE , 1970, Acta neurologica Scandinavica.

[9]  H. Moser,et al.  Farber's lipogranulomatosis. Report of a case and demonstration of an excess of free ceramide and ganglioside. , 1969, The American journal of medicine.

[10]  S. Gatt,et al.  Enzymatic hydrolysis of sphingolipids. 8. Further purification and properties of rat brain ceramidase. , 1969, Biochemistry.

[11]  A. Nilsson,et al.  The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. , 1969, Biochimica et biophysica acta.

[12]  S. Gatt.  [24] Enzymatic hydrolysis of sphingolipids , 1969 .

[13]  H. Moser,et al.  Ceramide and Ganglioside Accumulation in Farber's Lipogranulomatosis.∗ , 1967 .

[14]  J. Clausen,et al.  [Farber's disease (disseminated lipogranulomatosis). Clinical picture and summary of the chemical findings]. , 1967, Helvetica paediatrica acta.

[15]  A. E. Claireaux,et al.  THE PATHOLOGY OF LIMB ISCHAEMIA , 1967, The Ulster Medical Journal.

[16]  S. Farber,et al.  THE “LIPOGRANULOMATOSIS” SYNDROME; REVIEW, WITH REPORT OF PATIENT SHOWING MILDER INVOLVEMENT* , 1967 .

[17]  M. Sribney.  Enzymatic synthesis of ceramide. , 1966, Biochimica et biophysica acta.

[18]  S. Gatt.  Enzymatic hydrolysis of sphingolipids. I. Hydrolysis and synthesis of ceramides by an enzyme from rat brain. , 1966, The Journal of biological chemistry.

[19]  C. Pearson,et al.  A disorder of mucopolysaccharide metabolism with articular, respiratory, and neurologic manifestations , 1966 .

[20]  D. Cogan,et al.  Retinopathy in a case of Farber's lipogranulomatosis. , 1966, Archives of ophthalmology.

[21]  S. Abul-Haj,et al.  Farber's disease , 1962 .

[22]  R. Zetterström.  Disseminated Lipogranulomatosis (Farber's Disease) , 1958 .

[23]  S. Farber,et al.  Lipogranulomatosis; a new lipo-glycoprotein storage disease. , 1957, Journal of the Mount Sinai Hospital, New York.